Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BioDigest
- Development stage
- Unknown
- Lead developer
- Takgene
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
BioDigest is an oral probiotic supplement developed and marketed by Takgene. The active ingredient in BioDigest is the probiotic yeast *Saccharomyces boulardii* (5 billion CFU per sachet). It is designed to support gastrointestinal health by balancing the intestinal microbiota, protecting the gut lining, and boosting local immune responses. BioDigest is primarily used to prevent and treat various forms of diarrhea, including antibiotic-associated diarrhea, viral and bacterial diarrhea (such as *Clostridium difficile* infection), and traveler's diarrhea. It is also utilized as an adjuvant therapy to improve symptoms of *Helicobacter pylori* infection and prevent gastric and duodenal ulcers.
- Brand names
- BioDigestTakgene BioDigest
- Other names
- Saccharomyces boulardii
Beyond the preview
Go deeper on BioDigest.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioDigest.